|
Re: BiOasis Presents at BIO Investor Forum Oct 17th
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 17, 2018 07:59PM
|
|
Re: Jardiance??
|
4
|
Resverlogix Corp.
|
Oct 17, 2018 12:23PM
|
|
Re: Jardiance??
|
2
|
Resverlogix Corp.
|
Oct 17, 2018 09:49AM
|
|
Re: Jardiance??
|
4
|
Resverlogix Corp.
|
Oct 16, 2018 11:57PM
|
|
Re: HDL function is associated with atherosclerotic burden and cardiovascular outcomes in T2D
|
2
|
Resverlogix Corp.
|
Oct 16, 2018 06:45PM
|
|
Epigenetic drugs, cardiometabolic disease and atherosclerosis
|
3
|
Resverlogix Corp.
|
Oct 16, 2018 04:45PM
|
|
HDL function is associated with atherosclerotic burden and cardiovascular outcomes in T2D
|
4
|
Resverlogix Corp.
|
Oct 16, 2018 04:34PM
|
|
Re: BTI just filed a Other securityholders documents - English
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 16, 2018 01:22PM
|
|
Re: Resverlogix H2 2018 events
|
4
|
Resverlogix Corp.
|
Oct 16, 2018 11:51AM
|
|
Re: Arvinas /ARVN dBET vs iBET
|
4
|
Zenith Epigenetics
|
Oct 13, 2018 03:41PM
|
|
Re: The countdown to 250
|
3
|
Resverlogix Corp.
|
Oct 12, 2018 11:41AM
|
|
Re: Abstract - first example of a "curative" effect?
|
4
|
Resverlogix Corp.
|
Oct 11, 2018 08:27AM
|
|
Re: The countdown to 250
|
6
|
Resverlogix Corp.
|
Oct 10, 2018 04:32PM
|
|
The countdown to 250
|
5
|
Resverlogix Corp.
|
Oct 10, 2018 12:35PM
|
|
Slides up for "LDL-C: DONE DEAL, NEXT EPIGENETICS?" Symposium
|
5
|
Resverlogix Corp.
|
Oct 10, 2018 10:15AM
|
|
BiOasis Presents at BIO Investor Forum Oct 17th
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 08, 2018 05:40PM
|
|
Zenith presents at BIO Investor Forum Oct 17th
|
4
|
Zenith Epigenetics
|
Oct 08, 2018 05:39PM
|
|
Resverlogix October 2018 events
|
7
|
Resverlogix Corp.
|
Oct 08, 2018 05:35PM
|
|
BiOasis AGM November 26, 2018
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 06, 2018 11:45AM
|
|
Re: BD-selectivity vs. BET protein selectivity
|
5
|
Resverlogix Corp.
|
Oct 06, 2018 11:40AM
|
